Clinical Trial Update: CEA CAR-T Therapy After Cytoreduction in Colorectal Cancer Patients With Peritoneal Metastases [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update of a carcinoembryonic antigen (CEA) CAR-T cell therapy following cytoreduction in patients with colorectal cancer and peritoneal m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer with Peritoneal Metastases

Drugs mentioned

• CEA CAR-T therapy (CEA-targeted CAR-T cell therapy)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Peritoneal Metastases From Colorectal Cancer | Phase 1 | Status: RECRUITING